ライフサイエンスコーパス: VR

1 VR acceptability was high; 84/93 (90%) "very much liked

2 VR entails a lot of potential for the future research in

3 VR has long featured in studies of Drosophila melanogast

4 VR play did not induce significant post-VR postural inst

5 VR rats showed escalating DA overflow with increasing ra

6 VR surgical planning was performed on virtual models.

7 VR-CAP was more effective than R-CHOP in patients with n

8 VR-PAH and VN-PAH can be differentiated with the use of

9 VR-SIM confirmed detection of positive surgical margins

10 VR/AR differ in both of these aspects from natural envir

11 In the safety population (100 R-CHOP and 101 VR-CHOP patients), grade >/= 3 adverse events included n

12 -up of 34 months, with 25% (R-CHOP) and 18% (VR-CHOP) of patients having had PFS events, the hazard r

13 lity Questionnaire for Children (CVAQC), (2) VR QoL with the Impact of Vision Impairment for Children

14 luating 2 doses of a combination VCV/MK-2048 VR, both rings were found to be safe and well tolerated.

15 s with food, head-fixed flies exploring a 2D VR respond to optogenetic activation of sugar-sensing ne

16 adigms, we then demonstrate that flies in 2D VR adapt their behavior in response to optogenetically d

17 terindividual variability of striatal D2/3R (VR = 1.26, p < .0001) and DAT (VR = 1.31, p = .01) avail

18 b 1.3 mg/m(2) intravenously on days 1 and 4 (VR-CHOP).

19 These trees correctly identified 5 of 5 VR-PAH patients in the validation cohort.

20 e or more doses of study drug (91 R-CHOP, 92 VR-CHOP).

21 CT data were transferred and rendered into a VR environment.

22 ve and life-like sculpture of a human into a VR simulation, greater utilitarian actions continued to

23 just the position of blocks in 3D space of a VR scenario such that they had the feeling that they cou

24 Using innovative 3D techniques, we provide a VR-based platform for visualization of DNA/RNA sequences

25 with normal VR (n = 8), those with abnormal VR (n = 21) displayed higher central and pulmonary venou

26 Patients with abnormal VR displayed more severely impaired reactive hyperemia i

27 Product safety warnings that accompany VR headsets ban their use in children under age 13 years

28 ovement was stable both over time and across VR environments.

29 In addition, VR led to lower preoperative VAS stress score (differenc

30 tinomial logistic regressions using adequate VR for low U5MR countries and verbal autopsy data for hi

31 was 84.3 (standard deviation, SD, 6.4) after VR, and 64.3 (SD, 11.7) after standard preoperative expe

32 The variable regions (HVR-1, HVR-2 and VR-3) exhibit particularly high flexibility, and bioinfo

33 ity 3D models directly compatible for AR and VR applications.

34 the development and accessibility of AR and VR contents for bioinformatics and cheminformatics appli

35 preparing 3D models ready to use for AR and VR is time-consuming and requires a technical expertise

36 AR and VR technologies allow for stunning and immersive experie

37 Overall response rate with R-CHOP and VR-CHOP was 98% and 96%, respectively.

38 ility Questionnaire for Children (CVAQC) and VR QoL was assessed using the Impact of Vision Impairmen

39 FVA and VR QoL as perceived by children with glaucoma are reduce

40 associated with significantly lower FVA and VR QoL included, lower best-corrected visual acuity (BCV

41 Scores for FVA and VR QoL were decreased in children with glaucoma: median

42 al acuity (BCVA) (P < .0001 for both FVA and VR QoL), bilateral glaucoma (P = .04 for in FVA and P =

43 laucoma surgeries (P < .001 for both FVA and VR QoL).

44 ma surgeries had significantly lower FVA and VR QoL.

45 racterized from 0.100-50.0 ng/mL for GB- and VR-Tyr and 0.250-50.0 ng/mL for GA-, GD-, GF-, and VX/VM

46 y 2-s-long hippocampal motifs in both RW and VR that had similar structure, including phase precessio

47 to-N (N can be C, T or G) substitutions, and VR-containing target gene(s).

48 IR (as a continuous predictor over time) and VR (as a time-varying predictor) and the relation betwee

49 Binocular visual function (VF and VA) and VR QOL.

50 sualized before Calot triangle dissection at VR in 100% of cases, at NIR-C in 98.15%, and in 96.15% a

51 A dangerous variant identified at VR induced a "fundus first" approach.

52 igm in humans using a commercially available VR headset and a cross-platform game engine.

53 can be rendered using commercially available VR headsets or in a two-dimensional web browser such as

54 Of 8 DP residents, 6 practiced 5 basic VR tasks (median 1 trial to pass), and 7 of 8 practiced

55 ty map to define genetic differences between VR-PAH and VN-PAH, we found enrichment in vascular smoot

56 -varying predictor) and the relation between VR and other clinical outcomes.

57 d either vincristine (R-CHOP) or bortezomib (VR-CAP).

58 orty-six of 50 children (94%) completed both VR play sessions with no significant change from baselin

59 of laparoscopic surgical performance on both VR and porcine LCs, although at the expense of increased

60 We aimed to prospectively evaluate NIR-C, VR-AR, and x-ray intraoperative cholangiography (IOC) du

61 H (VR-PAH) accounts for a minority of cases, VR-PAH has a pronounced response to calcium channel bloc

62 The subtelomere structure of Chromosome VR implies that ancestral telomere damage was repaired b

63 ensive retinopathy (18.9%) was the commonest VR disease, followed by refractive errors referred for r

64 Consequently, VR technology might be an effective tool for rehabilitat

65 were fully adherent to 28 days of continuous VR use and found the VR acceptable.

66 riatal D2/3R (VR = 1.26, p < .0001) and DAT (VR = 1.31, p = .01) availabilities and synaptic dopamine

67 Currently described VR curricula consist of trainees practicing the same tas

68 The developing VR service in Bhutan is challenged by the spectrum of di

69 antitative VR research by validating digital VR display of computed tomography (CT) data of the orbit

70 The three-dimensional VR planning enabled the identification of 12 anatomical

71 ing safety and pharmacokinetic data, the DPV VR is promising for preexposure prophylaxis in postmenop

72 Durable VR seems to be feasible in a substantial proportion of p

73 The rates of durable VR did not significantly differ according to the VR defi

74 The pooled rates of durable VR remission were 51.4%, 39.3%, and 38.2% at 12, 24, and

75 eline testing preceded VR exposure, and each VR session was followed by post-VR testing of binocular

76 se strengths where a patient may show either VR or PTC, depending on the size of the latent reservoir

77 In this study, we enhance VR and provide evidence for quantitative VR research by

78 latively underexplored sensory interface for VR and AR technology that could, nevertheless, greatly e

79 ntially different genetic predisposition for VR-PAH.

80 ns and rats maintained on the last ratio (FR/VR 20) for 20-25 days.

81 Thus far, analysis of data extracted from VR applications was mainly qualitative.

82 Microarrays of cultured lymphocytes from VR-PAH and VN-PAH patients followed at Vanderbilt Univer

83 Scores for FVA, VR QoL, and HR QoL were reduced in children with glaucom

84 A), sarin (GB), soman (GD), cyclosarin (GF), VR, VX, and VM adducts to tyrosine (Tyr).

85 023, and 0.083 ng/mL for GA-, GB-, GD-, GF-, VR-, and VX/VM-Tyr, respectively.

86 onverse is also true: in order to build good VR technologies, one needs an intimate understanding of

87 e key challenges involved in generating good VR and how a sense of presence in a virtual environment

88 controls was found only for the hippocampus (VR, 1.14; p = 0.036; CVR, 1.30; p < 0.001), and lateral

89 mecourse of adaption was similar in both HMD-VR and CT.

90 ealthy individuals were placed in either HMD-VR or CT and trained on an identical visuomotor adaptati

91 However, HMD-VR participants utilized a greater cognitive strategy th

92 s by which visuomotor adaption occurs in HMD-VR appear to be more reliant on cognitive strategies.

93 isms of motor learning and adaptation in HMD-VR versus a conventional training (CT) environment have

94 ween implicit and explicit mechanisms in HMD-VR versus CT.

95 ptation on a visuomotor rotation task in HMD-VR yields similar adaptation effects in CT and whether t

96 Immersive, head-mounted virtual reality (HMD-VR) provides a unique opportunity to understand how chan

97 We developed a decision tree to identify VR-PAH patients on the basis of the results with validat

98 IMG/VR has a user-friendly interface that allows users to in

99 al detection rates over viral RefSeq and IMG/VR nearly 182-fold and 2.6-fold, respectively.

100 ome-assembled viral sequences, including IMG/VR and the Global Ocean Virome.

101 All of these features make IMG/VR v.2.0 a key resource for the study of viruses.

102 Here we present IMG/VR, the largest publicly available database of 3908 isol

103 ity and predictions of host specificity, IMG/VR v.2.0 now separates prokaryotic and eukaryotic viruse

104 Exposure to an immersive VR experience also led to higher APAIS score (difference

105 D image visualization, enabling an immersive VR experience with unhindered spatial interaction by the

106 OLD and FAIR MRI revealed gradually impaired VR to carbogen in HD mice.

107 The resultant impaired VR might hinder cerebral hemodynamics and increase brain

108 In VR, one is able to actively explore and interact with th

109 glaucoma (P = .04 for in FVA and P = .009 in VR QoL), and 3 or more glaucoma surgeries (P < .001 for

110 pect that the insights or skills acquired in VR/AR transfer to real-world settings.

111 s can, however, help flies to avoid areas in VR where they experience an aversive, optogenetically ge

112 presentations can be sufficiently engaged in VR.

113 d distance traveled were greatly enhanced in VR tasks with stereotypical trajectories.

114 e contraction-related genes were enriched in VR-PAH, suggesting a potentially different genetic predi

115 Perceptual information in VR/AR is less reliable than in natural environments, and

116 tergrader variability of the measurements in VR was much lower compared to measurements in the physic

117 however, manipulating the social presence in VR (i.e., embedding recording devices and humanoid avata

118 hat visual images of one's hand presented in VR influence the body schema and action performance.

119 ite sensitive to social stimuli presented in VR, as evidenced by contagious yawning, our results sugg

120 Despite impaired spatial selectivity in VR, most spikes occurred within approximately 2-s-long h

121 g random foraging and goal-directed tasks in VR.

122 ty appear to dominate and supersede those in VR.

123 on pathways and greater genetic variation in VR-PAH versus VN-PAH.

124 ignificantly inhibited contagious yawning in VR, even though participants were viewing a virtual envi

125 that these changes can explain the inferior VR in HD mice.

126 r GVs differ in vasodilator-responsive IPAH (VR-PAH) versus vasodilator-nonresponsive IPAH (VN-PAH).

127 ssory variability determinant (Avd ), but is VR-independent.

128 infection, we also predict population-level VR times for noncontrollers consistent with observations

129 availabilities and synaptic dopamine levels (VR = 1.38, p = .045) but not dopamine synthesis (VR = 1.

130 ship between vision-related quality of life (VR QOL; Visual Activities Questionnaire [VAQ] and the 25

131 n visualization in stereoscopic 3D, but many VR molecular-visualization programs are expensive and ch

132 At baseline, mean VR, HR, CAL, KTW, and TT values were similar (P >0.05).

133 deo-rate structured illumination microscopy (VR-SIM) for rapid high-resolution diagnostic imaging of

134 deo-rate structured illumination microscopy (VR-SIM) of the intact removed tumor surface as a practic

135 s and on-therapy VR > 24 than </= 24 months (VR at 12 months off-NAs: 75.0% versus 35.6%, P = 0.005).

136 We discuss the importance of multisensory VR and evaluate the experimental tension that exists bet

137 > 24 months offers higher chances of off-NA VR in patients with HBeAg-negative chronic hepatitis B.

138 core, 55.3 (standard deviation, 13.0; normal VR QoL, 96).

139 y); mean IVI-C score, 67.3 (SD, 14.4; normal VR QoL, 96); median PedsQL self-report, 78.8 (IQR, 67.4-

140 Compared with individuals with normal VR (n = 8), those with abnormal VR (n = 21) displayed hi

141 exercise, compared with patients with normal VR, would display poorer pulmonary endothelial function,

142 Our novel VR approach effectively combines the ecological validity

143 virtual reality head mounted display (Oculus VR).

144 As such, this study attests the ability of VR to provide similar quantitative data alongside the ad

145 titative data alongside the added benefit of VR interfaces.

146 These results imply that the contribution of VR applications to health in older adults will neither b

147 ggest that the increased surface coverage of VR-SIM could also provide added value for detection and

148 we considered the highest realistic form of VR: immersive videos.

149 In this article, we review the history of VR displays, including the philosophical origins of VR,

150 average 9% from baseline after 60 minutes of VR exposure (P = .06).

151 lays, including the philosophical origins of VR, before discussing some key challenges involved in ge

152 A clinically relevant review of VR-SIM images of 34 unfixed and uncut prostate core biop

153 the first 10 minutes of the first session of VR play, 2 girls (aged 5 and 6 years) and 1 boy (aged 7

154 l environment after 4-5 repeated sessions of VR.

155 o have important applications for the use of VR in psychological research.

156 In conjunctival MLs, the use of VR with Melan-A and HMB45 provides substantial sensitivi

157 peed, minimal complexity, and ease of use of VR-SIM could prove to be features in favor of adoption a

158 tailored viewing experience for a variety of VR/AR applications.

159 Training on VR simulators has been shown to improve technical perfor

160 al organisations are critical for optimising VR services, especially as rates of diseases such as dia

161 isone administered orally on days 1 to 5) or VR-CAP (R-CHOP regimen, but replacing vincristine with b

162 ents without NAT, N+ patients without NAT or VR; (2) R1-0 mm posterior-margin for the NAT group (P =

163 The overall VR measurements were 5.49% higher.

164 Although vasodilator-responsive PAH (VR-PAH) accounts for a minority of cases, VR-PAH has a p

165 ly through a head-mounted display (panoramic VR).

166 A Sony PlayStation VR headset was worn for 2 sequential play sessions (of 3

167 signed to either the treadmill training plus VR group (n=154) or treadmill training alone group (n=14

168 icantly lower in the treadmill training plus VR group than in the treadmill training group (incident

169 icantly lower in the treadmill training plus VR group than it had been before training (6.00 [95% CI

170 high risk for falls, treadmill training plus VR led to reduced fall rates compared with treadmill tra

171 ve 6 weeks of either treadmill training plus VR or treadmill training alone.

172 lls per 6 months for treadmill training plus VR).

173 re, and each VR session was followed by post-VR testing of binocular CDVA, refractive error, binocula

174 VR play did not induce significant post-VR postural instability or maladaption of the vestibulo-

175 Baseline testing preceded VR exposure, and each VR session was followed by post-VR

176 langiopancreatography, enabling preoperative VR exploration, and intraoperative augmented reality (AR

177 1 randomization to an immersive preoperative VR experience or standard preoperative experience strati

178 trated that patients exposed to preoperative VR had increased satisfaction during the surgical encoun

179 reconstitution (IR) is suggested to prevent VR.

180 Abnormal pulmonary VR was defined by the slope of increase in pulmonary pre

181 s, and that patients with abnormal pulmonary VR with exercise, compared with patients with normal VR,

182 ountries (n=122,757 deaths) had high-quality VR, and modelled data were used for 129 countries.

183 nce VR and provide evidence for quantitative VR research by validating digital VR display of computed

184 ion in the pre-hypertensive SH rat - raising VR and driving vascular remodelling.

185 Variability ratio (VR) and coefficient of variation ratio (CVR) were used t

186 groups as indexed by the variability ratio (VR) and coefficient of variation ratio (CVR).

187 ces were quantified using variability ratio (VR) and coefficient of variation ratio.

188 R)] or uncertain conditions [variable-ratio (VR)] for 55 1-h sessions.

189 odels and indicated a lower Variation Ratio (VR) (8.10%) of TBA at 6 simulated levels.

190 sition, tie-line length (TLL), volume ratio (VR), crude sample loading, pH and sodium chloride (NaCl)

191 rain vessel density and vascular reactivity (VR) to carbogen challenge of HD mice were monitored by 3

192 ized with virtual reality/augmented reality (VR/AR) and wearables capable of external measurements (e

193 When we use virtual and augmented reality (VR/AR) environments to investigate behaviour or train mo

194 raditional technologies for virtual reality (VR) and augmented reality (AR) create human experiences

195 ited recent developments in virtual reality (VR) and in-headset eye-tracking to test the impact of ac

196 high-tech visual aids using virtual reality (VR) and sensory substitution have been developed to supp

197 Three-dimensional virtual reality (VR) biliary anatomy models can be obtained via software

198 vigation task in new visual virtual reality (VR) contexts.

199 jective was to determine if virtual reality (VR) could provide a vehicle for sensory training, and de

200 Virtual reality (VR) enables precise control of an animal's environment a

201 Virtual reality (VR) enables protein visualization in stereoscopic 3D, bu

202 We use the fully immersive virtual reality (VR) environment CAVE (cave automatic virtual environment

203 the effect of exposure to a virtual reality (VR) environment preoperatively on patient-reported outco

204 tated by the development of virtual reality (VR) environments for head-fixed animals, allowing for qu

205 ast, three-dimensional (3D) virtual reality (VR) expands the realm of 2D image visualization, enablin

206 To address this issue, Virtual Reality (VR) has been proposed as a potential solution.

207 Augmented Reality (AR) and Virtual Reality (VR) in the fields of bioinformatics and cheminformatics

208 Virtual reality (VR) is a technology that is gaining traction in the cons

209 Virtual reality (VR) is becoming an increasingly important way to investi

210 then trained on a validated virtual reality (VR) laparoscopic cholecystectomy (LC) curriculum.

211 We established an immersive virtual reality (VR) platform to simultaneously measure behavior, physiol

212 ed deliberate practice on a virtual reality (VR) simulator results in improved technical performance

213 users reveal that augmented virtual reality (VR) simulators have the potential and capability to be u

214 Advances in Virtual Reality (VR) technologies allow the investigation of simulated mo

215 We used head-mounted virtual reality (VR) to place observers in immersive, dynamic real-world

216 Recent findings using virtual reality (VR) to realistically manipulate the length of whole extr

217 training with non-immersive virtual reality (VR) to target both cognitive aspects of safe ambulation

218 visualization framework in virtual reality (VR), designed to render a Manhattan plot in three dimens

219 de: (i) visualization using virtual reality (VR), which has implications in biology education and the

220 an easy-to-use interactive, virtual reality (VR)-assisted platform for integrated visual analysis of

221 llular calcium imaging in a virtual reality (VR)-based locomotion task, we investigate how the integr

222 odiment may be generated by virtual reality (VR).

223 e simulated using immersive virtual reality (VR).

224 exploring a two-dimensional virtual reality (VR).

225 ce on contagious yawning in virtual reality (VR).

226 ice, as animals performed a virtual-reality (VR) track running task.

227 , student, students, nurs*, virtual-reality, VR, "virtual reality", "augmented reality", clinical, sk

228 ve immune response to prevent viral rebound (VR) and control infection.

229 that express distinct vomeronasal receptor (VR) genes and localize to specific regions of the neuroe

230 e index, gingival index, vertical recession (VR), probing depth, clinical attachment level (CAL), ker

231 We recommend VR, which rarely requires specimen bleaching, as the sta

232 We reviewed data from vital registration (VR) and demographic and health surveys for information o

233 We used adequate vital registration (VR) data where available, and modelled cause-specific mo

234 on functional vision and on vision-related (VR) and health-related (HR) quality of life (QoL) in chi

235 e synthesis (VR = 1.12, p = .13) or release (VR = 1.08, p = .70) capacities were significantly greate

236 o discontinued NAs in virological remission (VR) and were followed for >/=12 months thereafter.

237 a template repeat (TR) to a variable repeat (VR) that results in adenine-to-random nucleotide convers

238 atment (NAT = 20%); 41 had venous resection (VR = 28%), and 70% received adjuvant chemotherapy.

239 ed that impaired pulmonary vascular reserve (VR) plays a central role linking these abnormalities, an

240 that bursting increases vascular resistance (VR) more than tonic stimulation (57.8 +/- 3.3% vs. 44.8

241 their classification as a vaccine responder (VR) or vaccine nonresponder (VNR).

242 =99% of patients had a virological response (VR) at the end of treatment.

243 sociated with improved virological response (VR) rates to antiviral therapy and decreased progression

244 ile range: 33.4-94.7), virological response (VR; <60 IU/mL) occurred in 96 of 111 (86.5%) patients.

245 we quantified the pattern of vitreo-retinal (VR) diseases presenting at the national referral hospita

246 a microbicide dapivirine (DPV) vaginal ring (VR) versus placebo in postmenopausal women.

247 Vaginal rings (VR) containing antiretroviral (ARV) drugs can be utilize

248 ion by assessing LVST-mediated ventral root (VR) response latencies, manipulating synaptic responses

249 Repeatedly watching the same VR movie significantly reduced both the anteroposterior

250 The subjects watched a 90-second VR simulation of railroad (rollercoaster) motion in moun

251 s of the results with validation in a second VR-PAH cohort from the University of Chicago.

252 l was analyzed with Ad Hoc imaging software (VR-RENDER), which provides a digital perfusion cartograp

253 nd challenging to use; work only on specific VR headsets; rely on complicated model-preparation softw

254 ine and other antipsychotics in TRS studies (VR = 1.84; 95%CI, 0.85-4.02).

255 study did not meet the co-primary subjective VR-OSDI measure (P = 0.7894).

256 1.38, p = .045) but not dopamine synthesis (VR = 1.12, p = .13) or release (VR = 1.08, p = .70) capa

257 We hypothesized that VR-PAH has a different molecular cause from VN-PAH that

258 g and in vivo techniques, we have shown that VR depends critically on respiratory modulation and reve

259 The VR setup is validated by replicating previous results in

260 The VR system consisted of a motion-capture camera and a com

261 In adult SH rats (n = 8), the VR response to bursting (44.6 +/- 3.9%) was not differen

262 the VR-CAP group (hazard ratio favoring the VR-CAP group, 0.63; P<0.001), a relative improvement of

263 cts ("flashbacks") in the days following the VR exposure.

264 eference point and predominantly follows the VR upon manipulations of optic flow against locomotion.

265 o 28 days of continuous VR use and found the VR acceptable.

266 eed to assess adequacy of drug dosing in the VR and measuring genital tissue drug concentrations to d

267 neural sequences that track position in the VR environment.

268 n the R-CHOP group versus 24.7 months in the VR-CAP group (hazard ratio favoring the VR-CAP group, 0.

269 end points were consistently improved in the VR-CAP group, including the complete response rate (42%

270 enia and thrombocytopenia were higher in the VR-CAP group.

271 at are modulated by animal's position in the VR.

272 ; 84/93 (90%) "very much liked or liked" the VR.

273 The onset of the VR response was also quicker for bursting stimulation (r

274 id not significantly differ according to the VR definition (hepatitis B virus DNA <200, < 2000, < 20,

275 However, females adapted more slowly to the VR stimuli as reflected by higher use of total (p = 0.00

276 The immediate response to watching the VR movie was an increased level of postural instability.

277 discontinue long-term NA therapy; on-therapy VR > 24 months offers higher chances of off-NA VR in pat

278 with HBeAg-negative patients and on-therapy VR > 24 than </= 24 months (VR at 12 months off-NAs: 75.

279 0, < 20,000 IU/mL) or duration of on-therapy VR in HBeAg-positive patients, but they were significant

280 being affected by the duration of on-therapy VR or consolidation therapy (>6 months in all studies).

281 ns and interactivity options offered through VR, we provide a new, interactive, three-dimensional rep

282 s the identifiability of users under typical VR viewing circumstances, with no specially designed ide

283 In a series of experiments, we used VR to assess the effects of the displacement of the virt

284 se findings indicate the advantages of using VR in the experimental study of awe, with methodological

285 web-based application that works on various VR setups and operating systems.

286 R, 1.30; p < 0.001), and lateral ventricles (VR, 1.56; p = 0.004).

287 s move in two dimensions (2D) using a visual VR environment that more closely captures an animal's ex

288 tained in the laser rooms and vitreoretinal (VR) operating theatres (including paediatric cases manag

289 % sodium citrate with a TLL of 46.38% (w/w), VR of 1.8, and 1.8% crude load at pH 7 without the prese

290 Main outcomes of interest were VR of adenovirus, EBV, human herpesvirus 6 (HHV6), cytom

291 The most widespread VR and AR systems use head-mounted displays, acceleromet

292 rates were 77.6% with R-CHOP and 82.0% with VR-CHOP; they were 65.1% versus 72.4% in patients with h

293 cing (WES) on 36 patients with IPAH: 17 with VR-PAH and 19 with VN-PAH.

294 for PFS was 0.73 (90% CI, 0.43 to 1.24) with VR-CHOP ( P = .611).

295 re training sessions to achieve effects with VR.

296 e key advantages of studying perception with VR is that it allows an experimenter to probe perceptual

297 trait differences in negativity bias within VR.

298 ria2 protein structure and visualized within VR.

299 pancreatectomy (n = 117; P = 0.049); without VR or NAT (n = 87; P = 0.003); N+ without VR or NAT (n =

300 ut VR or NAT (n = 87; P = 0.003); N+ without VR or NAT (n = 50; P = 0.004).